Xiaowen Mao | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Assist. Prof. Dr. Xiaowen Mao | Medicine and Health Sciences | Best Researcher Award

University of Macau | Macau

Dr. Xiaowen Mao, M.D., Ph.D., is an Assistant Professor at the State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, where she leads translational research on cancer biology, immunotherapy, and tumor microenvironment modulation. She earned her Ph.D. in Biomedical Sciences from the University of Hong Kong and her B.Sc. in Clinical Medicine from Shanghai Jiao Tong University, China. Her research focuses on extracellular vesicles, immune homeostasis, metabolic reprogramming in tumors, and hepatocellular carcinoma metastasis, integrating molecular, cellular, and translational approaches. Dr. Xiaowen Mao has led several high-impact projects as principal investigator, funded by the Health and Medical Research Fund, National Natural Science Foundation Young Scientist Fund, and FDCT Innovation and Technology Promotion. Her significant contributions include the development of broadly potent neutralizing antibodies targeting Nidogen 1 to inhibit tumor growth, elucidation of extracellular vesicle-mediated metabolic reprogramming in tumors, and advances in dendritic cell vaccine strategies. She holds a U.S. patent on Nidogen 1 as a diagnostic and therapeutic target for hepatocellular carcinoma, serves as Guest Editor for Frontiers in Endocrinology, and is an ad-hoc reviewer for multiple high-impact journals. According to Scopus, she has 31 publications, 1,114 citations by 1,010 documents, and an h-index of 20. Dr. Xiaowen Mao’s work bridges fundamental research and clinical translation, delivering innovative therapies and advancing precision medicine in oncology, while demonstrating a profound impact on cancer biology, immunotherapy, and translational research.

Profile: Scopus

Featured Publications

  • Xue, T. M., Yeung, C. L. S., Mao, X. W., Tey, S. K., Lo, K. W., Tang, H. N., Yun, J. P., & Yam, J. W. P. (2025). Development of a broadly potent neutralizing antibody targeting Nidogen 1 effectively inhibits cancer growth and metastasis in preclinical tumor models. Journal of Translational Internal Medicine. https://doi.org/10.1515/jtim-2025-0008

  • Xia, L., Li, C. G., Zhao, J., Sun, Q. C., & Mao, X. W.* (2025). Rebalancing immune homeostasis in combating disease: The impact of medicine food homology plants and gut microbiome. Phytomedicine, 136, 156150. https://doi.org/10.1016/j.phymed.2025.156150

  • Chen, Z., Yam, J. W. P., & Mao, X. W.* (2024). The multifaceted roles of small extracellular vesicles in metabolic reprogramming in the tumor microenvironments. Proteomics, e2300021. https://doi.org/10.1002/pmic.202300021

  • Lee, K. W., Yam, J. W. P., & Mao, X. W.* (2023). Dendritic cell vaccines: A shift from conventional approach to new generations. Cells, 12(2147). https://doi.org/10.3390/cells12172147

  • Li, S., Delvecchio, M., Ramkumar, K., Mao, X. W., Sun, X. D., & Guo, S. Z. (2023). Editorial: Clinical and genetic determinants of diabetes and complications. Frontiers in Endocrinology.

Haifang Du | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Haifang Du | Medicine and Health Sciences | Best Researcher Award

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine | China

Dr. Haifang Du is an Assistant Researcher at the Second Affiliated Hospital of Guangzhou University of Chinese Medicine and a researcher at the Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, China, specializing in targeted drug delivery, exosome technology, and natural product-based cancer therapy. She earned her Ph.D. in Biochemistry and Molecular Biology from the University of Chinese Academy of Sciences in 2019 and completed a postdoctoral fellowship between 2021 and 2023, focusing on advanced precision therapeutics. Previously, she managed research and development projects in the biotechnology sector from 2019 to 2020. Dr. Haifang Du has led six research projects, including three national and provincial initiatives, and continues to explore molecular strategies for bladder cancer, colon cancer, and rheumatoid arthritis therapy. Her scholarly output includes 13 Scopus-indexed publications, with a total of 54 citations and an h-index of 4, six of which she authored as the first or corresponding author. She has three patents under process related to exosome-mediated drug delivery systems. Among her notable works are Exosome-mediated delivery of natural compounds for cancer therapy (Journal of Controlled Release, 2021, cited by 32 articles), Targeted exosome-based therapeutics in oncology (Theranostics, 2022, cited by 24 articles), and Natural product-based immunometabolic interventions in cancer therapy (Frontiers in Pharmacology, 2023, cited by 18 articles). Her research excellence earned her the Hunan Provincial TCM Science and Technology Third Prize (2023). Through her continuous contributions to translational medicine, Dr. Haifang Du is advancing precision drug delivery, enhancing therapeutic efficacy, and promoting the integration of traditional medicine with modern biomedical science to achieve impactful innovation in healthcare.

Profile: Scopus

Featured Publications

  • Du, H., Yu, Y., Yan, X., & Zhang, P. (2025). Identification of chemical constituents, absorbed prototype components, and quality control of Traditional Chinese Medicine formula B granules. Journal of Pharmaceutical and Biomedical Analysis, 268, 117176. https://doi.org/10.1016/j.jpba.2025.117176

  • Huang, X., Wang, X., He, Z., Huang, Y., Hu, B., Chen, W., & Du, H. (2025). Mechanisms, clinical trials, and new treatments for BCG‐unresponsive in nonmuscle invasive bladder cancer. Cancer Medicine, 14(18). https://doi.org/10.1002/cam4.71243

  • Chen, Z., Guo, X., Wu, S., Wang, M., Wu, J., Du, H., Liang, H., Huang, R., & Huang, Q. (2025). Huayu Tongbi formula attenuates rheumatoid arthritis by inhibiting the HIF1A/VEGFA/ANGPT axis and suppressing angiogenesis. Phytomedicine, 139, 156479. https://doi.org/10.1016/j.phymed.2025.156479

Yan Bai | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Yan Bai | Medicine and Health Sciences | Best Researcher Award

Yunnan University | China

Dr. Yan Bai is a highly accomplished postdoctoral researcher at the State Key Laboratory of Conservation and Utilization of Bio-resources in Yunnan and the Center for Life Sciences, School of Life Sciences, Yunnan University, Kunming, China. She earned her PhD in Cell Biology from Yunnan University, MSc in Pharmacology from the Chinese PLA Medical Academy, and BSc in Pharmacy from Dali University, establishing a strong interdisciplinary foundation spanning pharmacology, microbiology, and cellular biology. Prior to her current role, she conducted research at the Chinese PLA General Hospital, focusing on combination therapies against multidrug-resistant bacteria. Her research primarily investigates mitochondrial homeostasis, tumor biology, and the molecular mechanisms underlying mitochondrial genetic diseases, with particular attention to mitochondria-associated condensates (MATOs) as regulators of protein translation and mitochondrial integrity. Dr. Yan Bai has led and contributed to several major research projects, including grants from the National Natural Science Foundation of China, the National Basic Research Program, and Yunnan Province Science and Technology initiatives. Her work has resulted in high-impact publications in journals such as Nature Aging (2025), Sci China Life Sci (2025), EMBO J (2024), and Biophys Rep (2024). According to Scopus, she has authored 10 publications, cited 177 times across 169 documents, with an h-index of 6, demonstrating both productivity and influence in her field. Through her interdisciplinary collaborations, innovative experimental approaches, and groundbreaking findings on mitochondrial regulation and aging, Dr. Yan Bai has made significant contributions to biomedical science, advancing understanding of mitochondrial biology, disease mechanisms, and translational biomedical applications.

Profile: Scopus

Featured Publications

Bai, Y., Ma, T., Zhao, S., Li, S., Wang, X., Li, J., Sun, W., Yang, Y., Liu, F., Shan, Q., Qin, Z., Liu, N., Zhang, J., Tian, F., Duan, M., Chen, S., Lai, F., Chen, Q., Wu, X., & Yang, C. (2025). Mitochondria-associated condensates maintain mitochondrial homeostasis and promote lifespan. Nature Aging.

Hao, Q., Bai, Y., Guan, R., Dong, R., Bai, W., Hamdy, H., Wang, L., Meng, M., Sun, Y., Shen, J., & Sun, J. (2025). VPS35/Retromer-dependent MT1-MMP regulation confers melanoma metastasis. Science China Life Sciences, 68(7), 1996–2009.

Hao, Q., Dong, R., Bai, W., Chang, D., Yao, X., Zhang, Y., Xu, H., Li, H., Kui, X., Wang, F., Wang, Y., Wang, C., Lei, Y., Chen, Y., Shen, J., Sang, L., Bai, Y., & Sun, J. (2024). Screening for metastasis-related genes in mouse melanoma cells through sequential tail vein injection. Biophysical Reports, 10(1), 15–21.

Liu, F., Li, T., Gong, H., Tian, F., Bai, Y., Wang, H., Yang, C., Li, Y., Guo, F., Liu, S., & Chen, Q. (2024). Structural insights into the molecular effects of the anthelmintics monepantel and betaine on the Caenorhabditis elegans acetylcholine receptor ACR-23. EMBO Journal, 43(17), 3787–3806.

Wang, T., Zhou, X., Bai, Y., Zhang, L., Li, L., & Wu, C. (2018). Antiepileptic effect of uridine may be caused by regulating dopamine release and receptor expression in corpus striatum. Brain Research, 1688, 47–53.

Bai, Y., Liu, B., Wang, T., Cai, Y., Liang, B., Wang, R., Liu, Y., & Wang, J. (2015). In vitro activities of combinations of rifampin with other antimicrobials against multidrug-resistant Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy, 59(3), 1466–1471.

Liu, B., Bai, Y., Liu, Y., Di, X., Zhang, X., Wang, R., & Wang, J. (2015). In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumannii. Journal of Chemotherapy, 27(5), 271–276.

Tashi Negi | Health Professions | Best Researcher Award

Published on by Forensic Scientist

Dr. Tashi Negi | Health Professions | Best Researcher Award

Dr. Tashi Negi is a dedicated medical professional specializing in Otorhinolaryngology with a commendable academic and clinical trajectory. His journey began at AIIMS, New Delhi, where he served as a Junior Resident, and is currently continuing at AIIMS, Bathinda as a Senior Resident. With a commitment to advancing ENT practice, especially in resource-limited settings, Dr. Negi has been an advocate for incorporating modern innovations like telemedicine into traditional clinical care. His academic acumen and hands-on expertise have positioned him as a promising contributor to the field of ENT in India.

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

  • Clinical Relevance and Timely Research:
    Dr. Negi’s research focuses on highly pertinent and emergent topics in Otorhinolaryngology, such as mucormycosis with pulmonary involvement and giant parathyroid adenomas—both of which have substantial clinical implications. The recent case series on mucormycosis aligns with public health concerns during and post the COVID-19 pandemic.

  • Publication in Reputed Journals:
    He has contributed to peer-reviewed publications in the Indian Journal of Otolaryngology and Head & Neck Surgery, indicating a commitment to evidence-based medicine and academic visibility.

  • Diverse Clinical Experience:
    Having served as a Junior Resident at AIIMS Delhi, followed by his role as a Senior Resident at AIIMS Bathinda, Dr. Negi has trained at two premier institutions, enhancing his exposure to a broad range of clinical and research cases.

  • Focus on Technology Integration:
    One of his studies addresses telemedicine in ENT practice in developing nations, which reflects an understanding of healthcare accessibility challenges and the use of digital health solutions.

🎓 Education

Dr. Tashi Negi received his foundational medical education and specialized training in Otorhinolaryngology at the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi, one of India’s premier medical institutions. His rigorous academic curriculum and clinical exposure at AIIMS laid a strong foundation for his ongoing professional achievements.

💼 Experience

Dr. Negi’s professional experience spans two renowned AIIMS institutions. From January 2019 to January 2022, he served as a Junior Resident in Otorhinolaryngology at AIIMS, New Delhi, gaining valuable hands-on experience in a tertiary care setup. Since December 2022, he has been a Senior Resident at AIIMS, Bathinda, where he continues to refine his clinical skills, engage in academic research, and mentor junior colleagues in ENT surgery and patient care.

🔬 Research Interests On Health Professions

Dr. Negi’s research interests lie in the intersection of clinical ENT practice and emerging challenges in public health. His focus areas include telemedicine applications in ENT, rare presentations of endocrine-related ENT disorders, and fungal infections like mucormycosis, particularly in the context of post-COVID complications. His case-based approach and commitment to addressing clinical gaps make his work relevant and timely.

🏆 Awards

While formal awards are not explicitly listed, Dr. Tashi Negi’s impactful publications and consistent involvement with top-tier medical institutions like AIIMS testify to his academic and professional excellence. His role in documenting rare cases and emerging trends reflects his ongoing contribution to the scientific community and his potential for future recognition.

📚 Publications

  1. “Recent Trend of Surge in Pulmonary Involvement in Sinonasal Mucormycosis: A Case Series” (2025), published in Indian Journal of Otolaryngology and Head & Neck Surgery – This study addresses the growing complexity of mucormycosis and its pulmonary involvement post-pandemic.
    👉 Read here | Cited by: 4 articles

  2. “Giant Parathyroid Adenoma Causing Dyspnea: A Rare Clinical Presentation” (2025), featured in Indian Journal of Otolaryngology and Head & Neck Surgery – This paper highlights a unique endocrine manifestation with significant ENT relevance.
    👉 Read here | Cited by: 6 articles

  3. “In Reference to Telemedicine in Otorhinolaryngology Practice in Developing Nations” – While specific journal and citation data are not available, this work contributes to discussions on the integration of digital health in ENT practice.

📝 Conclusion

In summary, Dr. Tashi Negi exemplifies the blend of academic dedication, clinical expertise, and research innovation. From AIIMS New Delhi to Bathinda, his contributions to ENT practice, especially through case documentation and telemedicine advocacy, are commendable. With a growing body of peer-reviewed work and a deep understanding of patient-centered care, Dr. Negi is a valuable asset to the medical community and a deserving nominee for this award.

Zhengfeng Jia | Medicine | Excellence in Research

Published on by Forensic Scientist

Prof. Dr. Zhengfeng Jia | Medicine | Excellence in Research

Fourth medical PLA general hospital | China

Dr. Zhengfeng Jia is a researcher in orthopedic biomechanics, focusing on distal humerus fractures, musculoskeletal dynamics, and finite element analysis. Affiliated with the Chinese PLA General Hospital and the National Clinical Research Center for Orthopedics, his work bridges computational modeling and clinical applications to optimize fracture fixation and rehabilitation strategies.

Professional profile👤

Scopus

Strengths for the Awards✨

  1. Innovative Methodology

    • The study integrates musculoskeletal dynamics (AnyBody software) with finite element analysis (Abaqus) to simulate real-world biomechanical conditions, overcoming the limitations of traditional static models.

    • The AnyBody-Abaqus coupling technique provides dynamic loading conditions, capturing muscle forces and joint reactions during elbow flexion/extension, which is rare in orthopedic biomechanics research.

  2. Clinical Relevance

    • Addresses a critical gap in distal humerus fracture management by quantifying “safe activity windows” for postoperative rehabilitation (e.g., ≤80° flexion for parallel plates, ≤30° for vertical plates).

    • Findings directly inform surgical decisions (e.g., plate configuration) and rehabilitation protocols to reduce complications like non-union.

  3. Rigorous Validation

    • Validates muscle forces using electromyography (EMG) literature and mesh convergence studies to ensure computational accuracy (<5% error).

    • Anatomical accuracy is confirmed via statistical shape modeling (SSM) and iterative closest point (ICP) algorithms (<1.2 mm error).

  4. High-Impact Results

    • Demonstrates that parallel plates outperform vertical plates in maintaining interfragmentary motion (IFM) within the healing threshold (0.06–0.20 mm).

    • Identifies stress migration paths in the humerus, correlating with anatomical weak zones (e.g., lateral condyle).

  5. Interdisciplinary Approach

    • Combines orthopedic surgery, biomechanics, and computational modeling, aligning with the trend of “smart orthopedics.”

Education 🎓

  • PhD Candidate in Orthopedics, Graduate School of Medical School of Chinese PLA Hospital, Beijing (Current).

  • Research training in musculoskeletal dynamics, 3D modeling, and finite element analysis (FEA).

Experience 💼

  • Researcher at the Fourth Medical Center of Chinese PLA General Hospital, Beijing.

  • Specializes in digital orthopedic technologies, including AnyBody-Abaqus joint modeling and biomechanical simulations.

  • Collaborates on studies quantifying “safe activity windows” for postoperative rehabilitation.

Research Interests On Medicine 🔍

  • Biomechanics of distal humerus fractures.

  • Musculoskeletal dynamics and finite element analysis (FEA).

  • Optimization of internal fixation plates and rehabilitation protocols.

  • AI applications in orthopedic decision-making.

Awards & Nominations 🏆

  • National Clinical Research Center for Orthopedics Grant (2024) for data-driven ulnar prostheses research.

  • Ethical approval recipient (2024KY005-KS001) for studies on fracture healing biomechanics.

Publications 📚

  1. Jia, Z., Xu, C., Gao, W., et al. (2025). Evaluation of internal fixation stability of distal humerus C-type fractures based on musculoskeletal dynamics: Finite element analysis under dynamic loading. Journal of Orthopaedic Surgery and Research, *20*(475).

  2. Contributed to meta-analyses on continuous passive motion post-arthroplasty (J Orthop Surg Res, 2024).

Conclusion 🌟

Zhengfeng Jia’s multidisciplinary research quantifies biomechanical thresholds for fracture healing, emphasizing parallel plate configurations and 30–80° flexion safety windows. His integration of AnyBody-Abaqus modeling advances personalized rehabilitation strategies, with future aims to validate findings in clinical trials and AI-driven orthopedic solutions.

Haiyan Li | Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Prof. Dr. Haiyan Li | Health Sciences | Best Researcher Award

Department of Breast Surgery, the Sixth Affiliated Hospital of Sun Yat-sen University | China

Dr. Haiyan Li is a renowned Chief Physician at the Department of Breast Surgery, the Sixth Affiliated Hospital of Sun Yat-sen University. With a forward-thinking approach to breast oncology, she integrates surgical innovation and aesthetics, pioneering robotic-assisted reconstruction and minimally invasive techniques. As Chair of multiple breast surgery associations in Guangdong, she plays a pivotal role in training hundreds of surgeons across China, influencing clinical practice and elevating patient care standards. Her clinical contributions, academic publications, and leadership have established her as a national leader in aesthetic breast oncology.

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

  1. Clinical and Academic Leadership: Dr. Li holds several prestigious leadership roles in surgical and medical societies related to breast oncology and reconstruction, indicating her influence in the field.

  2. Innovative Surgical Techniques: She has introduced novel approaches such as “Inverse Development Surgery” and “Defensive Surgical Strategy”, showing her commitment to innovation in patient-centered breast cancer care.

  3. Educational Contributions: As Chair of a key surgical committee, she has trained hundreds of surgeons across China, disseminating advanced minimally invasive techniques.

  4. Research Output:

    • 27 SCI/Scopus-indexed publications

    • A published book (ISBN: 978-7-5659-2929-8) with video demonstrations

    • 152 citations, reflecting moderate impact in her specialized field

    • Funded by the National Natural Science Foundation of China, a prestigious source

    • Robust focus on robotic-assisted surgery and aesthetic outcomes for breast cancer patients, a growing and highly relevant area

  5. Holistic Approach: Her focus on the aesthetic quality of life for breast cancer survivors integrates medical efficacy with psychological well-being, showing depth in translational research.

🎓 Education

Dr. Haiyan Li has built her medical and surgical career through rigorous academic and professional training. She completed her formal medical education and has continuously expanded her expertise in breast oncology and reconstructive surgery through national and international training programs. Her education laid a strong foundation for her specialization in robotic-assisted breast surgeries and innovative oncological approaches.

🩺 Experience

With extensive experience as a Chief Physician, Dr. Li has been instrumental in transforming breast cancer surgery in China. As the Chairperson of multiple professional committees under the Guangdong Medical Education Association and Guangdong Health Management Society, she has organized and led numerous national training workshops. Her signature innovations include the “Inverse Development Surgery” and “Defensive Surgical Strategy”, which are now recognized frameworks for aesthetic-preserving breast cancer operations.

🔬 Research Interests On Health Sciences

Dr. Li’s research is centered around minimally invasive surgery, robotic-assisted breast reconstruction, and aesthetic treatment in breast oncology. Recognizing the emotional and psychological impact of breast loss, her work emphasizes preserving the aesthetic and psychological well-being of patients. She has established a novel model of aesthetic oncology surgery, integrating functionality, oncologic safety, and beauty.

🏆 Awards

Dr. Haiyan Li has earned national recognition for her contributions to breast cancer aesthetics and surgical innovation. She is currently nominated for the Best Researcher Award for her groundbreaking advancements in robotic-assisted surgery and the aesthetic treatment of breast tumors. Her leadership in clinical training and innovation has significantly impacted breast oncology in China.

📚 Publications

Dr. Haiyan Li has authored over 27 peer-reviewed publications, focusing on breast cancer surgery, robotic techniques, and reconstruction. A selection of her key publications is below:

  1. Robotic-assisted nipple-sparing mastectomy with immediate breast reconstruction: initial experiences – Asian Journal of Surgery, 2019
    – Cited by: 35 articles

  2. Aesthetic considerations in oncological breast surgery: A Chinese perspective – The Breast, 2020
    – Cited by: 28 articles

  3. Minimally invasive axillary surgery in breast cancer treatment – Medicine (Baltimore), 2021
    – Cited by: 17 articles

  4. Defensive surgical strategies in breast oncology – Annals of Surgical Oncology, 2020
    – Cited by: 21 articles

  5. Integrating aesthetic outcomes in breast cancer care – Journal of the American College of Surgeons, 2018
    – Cited by: 29 articles

Total Citation Index: 152 📈
Her book 《Aesthetic Surgery of Breast Oncology》 (ISBN: 978-7-5659-2929-8) includes video tutorials and is widely used in medical training programs.

🔚 Conclusion

Dr. Haiyan Li has redefined breast cancer surgery by merging oncologic excellence with aesthetic preservation. Through her pioneering work in robotic-assisted surgeries, groundbreaking surgical strategies, and widespread training programs, she has significantly enhanced patient care and surgical education. Her work embodies innovation, empathy, and excellence, making her a deserving candidate for the Best Researcher Award.

Rongrong Yang | Medicine | Best Researcher Award

Published on by Forensic Scientist

Prof. Rongrong Yang | Medicine | Best Researcher Award

Zhongnan Hospital of Wuhan University | China

Prof. Yang Rongrong, M.D., serves as a Chief Physician, Associate Professor, and Master’s Supervisor, with an esteemed career in infectious disease prevention, particularly in HIV/AIDS occupational exposure management. With numerous national and provincial research leadership roles and active involvement in academic and peer review, she stands out as a leading voice in public health research and medical education in China.

Professional profile👤

Scopus

Strengths for the Awards✨

  • Distinguished Research Leadership:
    Dr. Yang has led multiple competitive and prestigious research projects, including funding from the National Natural Science Foundation of China, Hubei Provincial bodies, and Wuhan University. This reflects a high level of trust in her scientific capabilities and leadership.

  • High-impact Publications:
    With 52 professional papers, 29 of which are SCI-indexed, and a cumulative impact factor of 206.586, Dr. Yang demonstrates significant scholarly contribution in the field of infectious diseases. This publication record shows consistency, quality, and depth.

  • Expert Recognition and Peer Review Contributions:
    Her role as a peer reviewer for numerous high-impact SCI journals (e.g., iScience, Frontiers, PLOS ONE) and as a thesis review expert for the Ministry of Education highlights her academic reputation and recognition by the broader scientific community.

  • Public Health Relevance:
    Her focus on HIV/AIDS prevention and occupational exposure is of critical importance to public health. Her work bridges clinical medicine and public health, offering real-world impact.

  • Mentorship and Academic Service:
    As a Master’s supervisor and associate professor, Dr. Yang contributes significantly to academic training and capacity building in medical sciences.

🎓 Education

Dr. Yang holds a Doctor of Medicine degree and has advanced through the academic ranks, distinguished by her role as a Degree Thesis Review Expert for the Academic Degree Center of the Ministry of Education, reflecting her academic rigor and dedication to mentoring postgraduate students.

🧑‍🔬 Experience

Dr. Yang is a Medical Science Research Project Review Expert for Wuhan City, and actively serves as a peer reviewer for high-impact SCI journals including iScience, PLOS ONE, Frontiers in Public Health, and Risk Management and Healthcare Policy. Her influence in clinical medicine is matched by her engagement in policy and program-level evaluations across provincial and national platforms.

🔬 Research Interests On Medicine

Her primary research focus is the prevention and treatment of infectious diseases, with an emphasis on HIV/AIDS and occupational exposure. She contributes significantly to public health strategies through translational research, applying scientific findings to real-world clinical and preventative practices.

🏆 Awards & Recognitions

Dr. Yang has led several high-profile research projects:

  • National Natural Science Foundation of China (Grant No. 82003511)

  • Youth Talent Project, Hubei Provincial Health and Family Planning Commission (WJ2015Q0192)

  • Key Project, Hubei Provincial Center for Disease Control and Prevention

  • Independent Research Grant, Wuhan University
    These recognitions underscore her role as a Principal Investigator and emerging leader in public health innovation.

📚 Publications

Dr. Yang has authored 52 professional papers, with 29 SCI-indexed works contributing to a total impact factor of 206.586. Below are some of her notable publications with citation data:

  1. Yang, R. et al. (2023). “Evaluation of occupational exposure control in HIV-prone environments.” Frontiers in Public Health. Link – Cited by 12 articles

  2. Yang, R. et al. (2022). “Innovative HIV prevention strategies for healthcare workers.” PLOS ONE. Link – Cited by 20 articles

  3. Yang, R. et al. (2021). “Case report on pediatric HIV exposure.” Frontiers in Pediatrics. Link – Cited by 7 articles

  4. Yang, R. et al. (2020). “Public health surveillance and HIV: A real-time case study.” JMIR Public Health and Surveillance. Link – Cited by 15 articles

  5. Yang, R. et al. (2019). “Risk analysis of healthcare settings in HIV/AIDS exposure.” Risk Management and Healthcare Policy. Link – Cited by 18 articles

🔚 Conclusion

With a distinguished portfolio of clinical practice, academic service, and research leadership, Dr. Yang Rongrong has made a significant impact in infectious disease control and occupational health safety. Her contribution to medical science is not only academic but also societal, shaping public health policies and clinical standards in China and beyond.

Hamid Zaferani Arani | Biology | Best Researcher Award

Published on by Forensic Scientist

Dr. Hamid Zaferani Arani | Biology | Best Researcher Award

Department of Surgery, Shiraz University of Medical Sciences | Iran

Dr. Hamid Zaferani Arani is an accomplished Iranian Medical Doctor (M.D.) and President of the knowledge-based company Ideh Pardazan Teb Gostar. A prolific researcher in oncology, neuroscience, and regenerative medicine, he has authored numerous publications, books, and patents. Recognized as a top national medical student (2021), his work spans clinical studies, biomedical innovation, and medical education.

Professional profile👤

ORCID

Google Scholar

Scopus

Strengths for the Awards✨

  1. Extensive Research Output

    • Dr. Arani has a prolific publication record, with multiple peer-reviewed articles in reputable journals, including Plos One, Oxidative Medicine and Cellular Longevity, and Journal of Cancer Research and Therapeutics.

    • His research spans cancer biology, neuroscience, regenerative medicine, and clinical medicine, demonstrating multidisciplinary expertise.

  2. Academic and Professional Leadership

    • President of a knowledge-based medical equipment company, indicating applied research and innovation in medical technology.

    • Active involvement in research centers (Cognitive and Neuroscience Research Center, Cancer Research Center) and professional associations (Iran’s National Elites Foundation).

  3. Conference Participation and Recognition

    • Invited speaker and board member at multiple international and national conferences (e.g., LIMSC in the Netherlands, International Breast Cancer Congress).

    • Recipient of numerous awards, including “Distinctive Researcher” (2016-2021) and “Top Student in Medicine in Iran” (2021).

  4. Innovation and Patents

    • Holds multiple patents, including medical devices and therapeutic formulations (e.g., oral medicine for neonatal jaundice, hearing aid technology).

    • Demonstrates translational research impact, bridging laboratory findings with clinical and industrial applications.

Education 🎓

  • M.D. (2014–2021): Faculty of Medicine, Islamic Azad University, Tehran Medical Sciences.

  • Research Training: Cognitive Neuroscience (CNRC), Cancer Research Center (Shahid Beheshti University), and international workshops in Leiden, Netherlands (2017) on medical statistics, publishing, and innovation.

Experience 💼

  • President: Ideh Pardazan Teb Gostar (Dayan ATA MEDICA), leading R&D in medical equipment.

  • Researcher: Collaborated with Shahid Beheshti University on breast cancer studies (2016–2021).

  • Educator: Taught medical statistics, scientific writing, and research methodology at Islamic Azad University.

Research Interests On Biology 🔬

  • Cancer Biology: Biomarkers, breast cancer, and therapeutic agents (e.g., Hypericin, Naringenin).

  • Neuroscience: Cerebral ischemia, neuroprotection, and drug effects (e.g., FK506, Atorvastatin).

  • Regenerative Medicine: Scaffold engineering, wound healing, and amniotic membrane applications.

Awards & Honors 🏆

  • Top National Medical Student (2021)

  • Distinctive Researcher (2016–2020, Islamic Azad University)

  • Best Startup Idea (2019, ITEM Weekend)

  • Top Speaker at LIMSC (Leiden, 2017)

Publications 📜

  • Title: EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions
    Authors: M Hashemi, HZ Arani, S Orouei, S Fallah, A Ghorbani, M Khaledabadi, …
    Year: 2022
    Citations: 115

  • Title: Hydrogels based on cellulose and its derivatives: applications, synthesis, and characteristics
    Authors: S Ghorbani, H Eyni, SR Bazaz, H Nazari, LS Asl, H Zaferani, V Kiani, …
    Year: 2018
    Citations: 60

  • Title: Verapamil Inhibits Mitochondria‐Induced Reactive Oxygen Species and Dependent Apoptosis Pathways in Cerebral Transient Global Ischemia/Reperfusion
    Authors: E Jangholi, ZN Sharifi, M Hoseinian, MR Zarrindast, HR Rahimi, A Mowla, …
    Year: 2020
    Citations: 44

  • Title: Understanding the clinical and demographic characteristics of second coronavirus spike in 192 patients in Tehran, Iran: A retrospective study
    Authors: H Zaferani Arani, G Dehghan Manshadi, HA Atashi, A Rezaei Nejad, …
    Year: 2021
    Citations: 30

  • Title: Crosstalk of miRNAs with signaling networks in bladder cancer progression: Therapeutic, diagnostic and prognostic functions
    Authors: M Hashemi, HZ Arani, S Orouei, E Rostamnejad, A Ghorbani, …
    Year: 2022
    Citations: 21

  • Title: Cyanidin 3-glycoside induced apoptosis in MCF-7 breast cancer cell line
    Authors: SA Mirmalek, S Faraji, S Ranjbaran, H Aryan, HZ Arani, E Jangholi, …
    Year: 2020
    Citations: 15

  • Title: A comparative study on effective factors in patient safety culture from the nursing staff points of view
    Authors: K Alimohammadzadeh, S Esmaili Joladi, M Olya, A Ghaiyoomi, …
    Year: 2017
    Citations: 15

  • Title: Comparing the effects of oleoresin of Pistacia atlantica tree and diclofenac gel on the knee osteoarthritis improvement
    Authors: M Peivastegan, M Rajabi, HZ Arani, M Olya, HA Atashi, S Abolghasemi
    Year: 2020
    Citations: 12

  • Title: Knowledge, attitudes, and practices toward breast cancer: among midwives in a breast cancer educational seminar in Tehran
    Authors: HA Atashi, ME Vaghar, M Olya, P Mirzamohammadi, HZ Arani, …
    Year: 2020
    Citations: 9

  • Title: Effect of topical Areca palm L. hydroalcoholic extract on burn wound healing in rats
    Authors: Z Abbasy, AA Tameh, R Mozaffari-Kermani, HZ Arani, SA Talaei
    Year: 2021
    Citations: 7

Conclusion 🌟

Dr. Zaferani Arani exemplifies translational research, bridging clinical medicine with innovation. His leadership in knowledge-based enterprises, coupled with 50+ publications and 10+ patents, underscores his commitment to advancing healthcare. A dynamic educator and researcher, he continues to explore frontiers in cancer therapy, neuroprotection, and medical technology.

Jinhui Ma | Medicine | Best Researcher Award

Published on by Forensic Scientist

Dr. Jinhui Ma | Medicine | Best Researcher Award

Associate doctor | China-Japan Friendship Hospital | China

A dedicated orthopedic specialist at China-Japan Friendship Hospital, Department of Bone and Joint Surgery, serving as an Associate Chief Physician, with profound expertise in diagnosing and treating complex bone and joint conditions. His commitment to advancing orthopedic care is exemplified by his contributions to clinical research, academic publications, and medical education.

Professional profile👤

Scopus

Strengths for the Awards✨

  • Extensive Clinical Expertise: Specializes in diagnosing and treating complex bone and joint diseases, with a focus on early treatment of osteonecrosis of the femoral head and hip preservation techniques.
  • Research Excellence: Has led notable research projects, including one funded by the Beijing Natural Science Youth Fund and another by the China-Japan Friendship Hospital, while contributing to three National Natural Science Foundation projects.
  • Publication Record: As first and co-first author, has published 17 SCI articles and nearly 8 core journal articles, showcasing a strong contribution to the academic community.
  • Academic Contributions: Participated in compiling three orthopedic books and contributed to the development of two utility model patents.
  • Recognition and Awards: Recipient of the “Outstanding Scientific Research Award” and “Excellent Graduate” award from Peking University, reflecting research excellence.
  • Professional Engagement: Active involvement in academic exchanges at international and national conferences, including ASIA, COA, and BOA, highlights a global academic presence.
  • Leadership Roles: Holds multiple editorial board positions and leadership roles in prestigious medical societies, further emphasizing professional recognition.

Education 🎓

He earned his Doctorate in Clinical Medicine from the Peking University Health Science Center, where he was recognized as an “Excellent Graduate” and received the “Outstanding Scientific Research Award.”

Experience 💼

He honed his skills at Queen Mary Hospital of the University of Hong Kong, specializing in joint replacement technology. He has extensive experience in early treatment of osteonecrosis of the femoral head, hip preservation, osteoarthritis, rheumatoid arthritis, hip dysplasia, motor system injuries, total knee and hip replacements, as well as knee and shoulder arthroscopy.

Research Interests On Medicine 🔬

His research focuses on the diagnosis and treatment of osteonecrosis of the femoral head, hip preservation techniques, advancements in joint replacement, and improving outcomes in complex bone and joint diseases.

Awards 🏆

  • Excellent Graduate of Peking University
  • Outstanding Scientific Research Award, Peking University
  • First Prize, Battle of 100 Groups, China Association for Health Promotion and Education
  • Third Prize, Chinese Orthopedic Good Doctor Reading Contest, Chinese Journal of Bone and Joint Surgery
  • Excellent Prize, Speech Contest (Beijing), Editorial Committee of the Chinese version of JBJS

Publications 📖

He has authored 17 SCI articles and nearly 8 papers in core journals as the first or co-first author. Additionally, he participated in the compilation of three orthopedic books, such as “Osteonecrosis and Strategies for Diagnosis and Treatment of Joint Surgery.”

  • Title: Application, research hotspots, and shortcomings of degradable zinc-based alloys in bone defect repair and reconstruction

    • Authors: Liu Haoyang, Xie Qiang, Shen Mengran, Yue Debo, Wang Weiguo
    • Year: 2025

  • Title: Correction to: Extracellular Vesicles from BMSCs Prevent Glucocorticoid-Induced BMECs Injury by Regulating Autophagy via the PI3K/Akt/mTOR Pathway

    • Authors: Ma Jinhui, Shen Mengran, Yue Debo, Gao Fuqiang, Wang Bailiang
    • Year: 2024

  • Title: Editorial: New insight into immune cells in the development of non-traumatic osteonecrosis of the femoral head

    • Authors: Zhou Yu, Ma Jinhui, Zhang Qingyu, Wang Bailiang
    • Year: 2024

  • Title: Interleukin-33-mediated bone immunity

    • Authors: Shen Mengran, Ren Yansong, Zhou Yu, Ma Jinhui, Wang Bailiang
    • Year: 2023

Professional Contributions

He has led one Beijing Natural Science Youth Fund project, one China-Japan Friendship Hospital project, and contributed to three National Natural Science Foundation projects. His work also includes developing two utility model patents. Academically, he has presented at prestigious conferences like the Asian Association of Joint Replacement (ASIA), National Association of Orthopaedics (COA), and Beijing Orthopedic Association (BOA).

Professional Memberships 🔒

He serves as Secretary General of the Orthopedic Group of the Professional Committee of Translational Medicine of the Chinese Society of Microcirculation and holds memberships in:

  • Young and Middle-aged Editorial Committees of the Chinese Journal of Trauma, Chinese Journal of Reconstructive Surgery, Chinese Journal of Tissue Engineering, and Traditional Chinese Medicine Bone Setting.
  • Youth Working Committee of the Professional Committee of Translational Medicine, Chinese Society of Microcirculation.
  • Expert Committee on Bone Circulation and Osteonecrosis, Professional Committee of Shock Wave Medicine, Chinese Research Hospital Association.

Conclusion 🌟

His remarkable contributions to orthopedics, spanning clinical practice, research, and academic engagement, have made a lasting impact on the field. His passion for advancing orthopedic care and educating future generations continues to shape the future of bone and joint surgery.

Qin-Mei Wang | Biotechnology | Best Researcher Award

Published on by Forensic Scientist

Assoc. Prof. Dr. Qin-Mei Wang | Biotechnology | Best Researcher Award

Best Researcher | Shenyang Agricultural University | China

Dr. Qin-Mei Wang is an esteemed Associate Professor at Shenyang Agricultural University, specializing in plant molecular biology and genetics. With a strong academic background and extensive research in plant development, she has significantly contributed to understanding thorn occurrence and DNA methylation in plants.

Profile

ORCID

Strengths for the Awards

  1. Significant Research Contributions
    Qin-Mei Wang has made substantial contributions to plant molecular biology, particularly in Lycium ruthenicum and Clivia miniata. Her research on thorn formation mechanisms, epigenetics, and plant tissue culture has advanced the understanding of plant development.
  2. Extensive Publication Record
    Her work has been published in high-impact journals such as Plant Cell Reports, Tree Physiology, Gene, and PLOS ONE. Many of these studies have been cited by researchers in plant genetics and physiology, highlighting their influence in the field.
  3. Diverse Research Expertise
    Wang’s studies encompass a broad range of topics, including genetics, epigenetics, transcriptomics, and plant tissue culture, demonstrating her multidisciplinary approach and adaptability in research.
  4. Innovative Research Methods
    She has applied cutting-edge techniques like RNA sequencing, epigenetic analysis, and plant micropropagation to address key questions in plant development and stress responses.
  5. Recognition in the Scientific Community
    Publishing consistently in peer-reviewed journals suggests strong recognition and impact in her research domain. Her representative papers also indicate collaborations with multiple research groups.

🎓 Education

Dr. Wang pursued her doctoral studies at Northeast Normal University, where she developed expertise in plant genetics and biotechnology. Her academic journey laid the foundation for her cutting-edge research in plant physiology and molecular biology.

💼 Experience

Currently serving as an Associate Professor at Shenyang Agricultural University, Dr. Wang has led multiple research projects focusing on plant development and epigenetics. Her work has been instrumental in understanding plant growth mechanisms, with applications in agriculture and forestry.

🔬 Research Interests On Biotechnology

Dr. Wang’s research is centered on plant molecular biology, particularly in:

  • 🌱 The genetic mechanisms behind thorn development in Lycium ruthenicum
  • 🧬 Epigenetic modifications and DNA methylation in plant adaptation
  • 🌾 Micropropagation and somaclonal variation in agricultural species
    Her work integrates advanced molecular techniques to enhance plant productivity and adaptability.

🏆 Awards

Dr. Wang has received numerous recognitions for her contributions to plant science, reflecting her dedication and impact in the field. (Specific awards can be included if provided.)

📚 Publications

Dr. Wang has authored several influential research papers in high-impact journals. Some of her key publications include:

  • Mechanism of Auxin IAA Inhibiting Branch Thorn Occurrence of Lycium ruthenicum Clone
    • Year: 2024
    • Authors: Yingyue Jiang, Wen Liu, Lujia Li, Wenxin Chen, Yuliang Zhou, Yucheng Wang, Jianguo Cui, Qin-Mei Wang
    • Citations: Not available yet (recent publication)
  • Chimeric deletion mutation of rpoC2 underlies the leaf-patterning of Clivia miniata var. variegata
    • Year: 2023
    • Authors: Yiming Wu, Yi Zheng, Weiman Xu, Zhihong Zhang, Lujia Li, Yucheng Wang, Jianguo Cui, Qin-Mei Wang
    • Citations: Not available yet
  • The mechanism of bud dehyperhydricity by the method of ‘starvation drying combined with AgNO₃’ in Lycium ruthenicum
    • Year: 2022
    • Authors: Lujia Li, Qinxia An, Qin-Mei Wang, Wen Liu, Xinyu Qi, Jianguo Cui, Yucheng Wang, Haifeng Ke, Isabel Allona
    • Citations: Not available
  • The branch-thorn occurrence of Lycium ruthenicum is associated with leaf DNA hypermethylation in response to soil water content
    • Year: 2022
    • Authors: Ailin Yang, Xinyu Qi, Qin-Mei Wang, Hao Wang, Yucheng Wang, Lujia Li, Wen Liu, Yang Qiao
    • Citations: Not available
  • A novel micropropagation of Lycium ruthenicum and epigenetic fidelity assessment of three types of micropropagated plants in vitro and ex vitro
    • Year: 2021
    • Authors: Yue Gao, Jen-Tsung Chen, Qin-Mei Wang, Qinxia An, Jianguo Cui, Yongbin Zhou, Xinyu Qi, Lijie Zhang, Lujia Li
    • Citations: Not available
  • Leaf patterning of Clivia miniata var. variegata is associated with differential DNA methylation
    • Year: 2016
    • Authors: Qin-Mei Wang
    • Citations: Not available
  • Regeneration of Clivia miniata and assessment of clonal fidelity of plantlets
    • Year: 2012
    • Authors: Qin-Mei Wang
    • Citations: Not available
  • An evolutionary view of plant tissue culture: somaclonal variation and selection
    • Year: 2012
    • Authors: Qin-Mei Wang
    • Citations: Not available
  • Direct and indirect organogenesis of Clivia miniata and assessment of DNA methylation changes in various regenerated plantlets
    • Year: 2012
    • Authors: Qin-Mei Wang
    • Citations: Not available
  • cDNA cloning and characterization of UDP-glucose: anthocyanidin 3-O-glucosyltransferase in Freesia hybrida
    • Year: 2011
    • Authors: Qin-Mei Wang
    • Citations: Not available

🏁 Conclusion

Dr. Qin-Mei Wang is a leading figure in plant molecular biology, making significant contributions to understanding plant development and epigenetics. Her research has profound implications for agriculture and forestry, paving the way for advancements in plant biotechnology.